1Oberg K,Hellman P,Kwekkeboom D. Neuroendocrine bronchial and thymic tumours:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up[J].Annals of Oncology,2010,(Suppl 5):v220-v222.
2Siegel R,Ward E,Brawley O. Cancer statistics,2011:The impact of eliminaying socioeconomic and racial disparities on premature cancer deaths[J].CA:A Cancer Journal for Clinicians,2011,(04):212-236.
3Govindan R,Page N,Morgensztern D. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years:analysis of the surveillance,epidemiologic,and end results database[J].Journal of Clinical Oncology,2006,(28):4539-4544.
7Micke P,Faldum A,Metz T. Staging small cell lung cancer:Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer-what limits limited disease[J].Lung Cancer,2002,(03):271-276.doi:10.1016/S0169-5002(02)00072-7.
8National Comprehensive Cancer Network. Oncology practice guideline.Small cell lung cancer[J].Oncology(Basel),2012.14-30.
9Murray N,Coy P,Pater JL. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer[J].Journal of Clinical Oncology,1993,(02):336-344.
10Pignon JP,Arriagada R,lhde DC. A meta-analysis of thoracic radiotherapy for small-cell lung cancer[J].New England Journal of Medicine,1992,(23):1618-1624.
